Trademark: 97520313
Status Date
Monday, April 8, 2024
Filing Date
Tuesday, July 26, 2022
Published for Opposition
Tuesday, September 12, 2023
5 Pharmaceutical preparations and substances for immunoglobulin therapy, the treatment or prevention of primary or secondary immunodeficiencies, autoimmune disease and disorders, blood and/or bleeding disorders and diseases; Pharmaceuticals for the treatment or prevention of blood and/or bleeding disorders; Blood products, namely, blood plasma and blood for medical or therapeutic purposes; Blood products, namely, immunoglobulins for medical and therapeutic purposes; Blood proteins for therapeutic use
10 Surgical and medical apparatus and instruments for the administration of subcutaneous therapy; Medical devices for the administration of subcutaneous therapy
Apr 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 8, 2024
Sou Extension 1 Granted
Apr 8, 2024
Sou Extension 1 Filed
Apr 8, 2024
Sou Teas Extension Received
Nov 7, 2023
Noa E-Mailed - Sou Required From Applicant
Sep 12, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 12, 2023
Published For Opposition
Aug 23, 2023
Notification Of Notice Of Publication E-Mailed
Aug 8, 2023
Approved For Pub - Principal Register
Jul 24, 2023
Teas/Email Correspondence Entered
Jul 24, 2023
Correspondence Received In Law Office
Jul 24, 2023
Teas Response To Office Action Received
Apr 24, 2023
Notification Of Priority Action E-Mailed
Apr 24, 2023
Priority Action E-Mailed
Apr 24, 2023
Priority Action Written
Apr 12, 2023
Assigned To Examiner
Aug 17, 2022
New Application Office Supplied Data Entered
Jul 29, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
